Takahashi Ryou-U, Prieto-Vila Marta, Hironaka Ai, Ochiya Takahiro
Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo.
Clin Chem Lab Med. 2017 May 1;55(5):648-656. doi: 10.1515/cclm-2016-0708.
microRNAs (miRNAs) constitute a large family of small, approximately 20-22 nucleotide non-coding RNAs that regulate the expression of target genes, mainly at the post-transcriptional level. Multiple studies report that miRNAs are involved in homeostatic maintenance and that aberrant expression of miRNAs is often observed in various types of diseases, including cancer. In cancer biology, miRNAs exert functional roles in tumor initiation, drug resistance, and metastasis. miRNAs are also secreted through small vesicles called exosomes, which are endosome-derived vesicles derived from various cell types including immune and tumor cells. In addition to cellular miRNAs (ce-miRNAs), secreted miRNAs (se-miRNAs) play important roles in cancer development and metastasis. Therefore, se-miRNAs in body fluids have been investigated as a promising biomarkers and therapeutic targets for cancer treatment. In this review, we summarize the current knowledge of miRNA functions in cancer development and discuss the potential clinical applications of se-miRNAs, e.g. as diagnostic markers and therapeutic targets.
微小RNA(miRNA)构成了一个大家族,其成员是大约20 - 22个核苷酸的小型非编码RNA,主要在转录后水平调控靶基因的表达。多项研究表明,miRNA参与体内稳态维持,并且在包括癌症在内的各种疾病中经常观察到miRNA的异常表达。在癌症生物学中,miRNA在肿瘤起始、耐药性和转移中发挥功能作用。miRNA还通过称为外泌体的小囊泡分泌,外泌体是源自包括免疫细胞和肿瘤细胞在内的各种细胞类型的内体衍生囊泡。除了细胞内miRNA(ce-miRNA)外,分泌型miRNA(se-miRNA)在癌症发展和转移中也发挥重要作用。因此,体液中的se-miRNA已被研究作为癌症治疗有前景的生物标志物和治疗靶点。在本综述中,我们总结了miRNA在癌症发展中功能的当前知识,并讨论了se-miRNA的潜在临床应用,例如作为诊断标志物和治疗靶点。